Results 76 - 100 from 188 for "iasi"
-
Ropharma Sells 8,850 Sqm Plot in Iasi to Penny for EUR2M
08.11.2021
Pharmaceutical company Ropharma (RPH.RO) held by several Cyprus-based companies has secured approval from shareholders to sell an 8,852 square meter plot on Soseaua Bucium in Iasi to Rewe more
-
Antibiotice Iasi Turnover Up 10% To RON161M, Net Profit Up Nearly 1% To RON19.3M In 1H/2021
07.26.2021
Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, reported sales of RON161.4 million in the first half of 2021, up 10.2% from the same period in 2020, per calculations by more
-
Ropharma Seeks to Sell Land in Iasi for EUR2M
07.07.2021
Pharmacy chain Ropharma (RPH.RO), owned by Mihai Miron, summoned shareholders for August 10 to approve the sale of a land plot in Iasi for RON2.02 million plus VAT. more
-
Antibiotice Iasi 1Q Sales Drop 10% To RON66M, Net Profit Of RON4.03M, Close To Level In Year-Earlier Period
05.12.2021
Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, on Wednesday reported sales of RON66.1 million for the first quarter of 2021, down 10.2% on the year, and a net profit of more
-
Antibiotice Iasi Shareholders Approve RON2.22M Dividends From 2020 Profit, At 0.6% Yield
04.21.2021
Shareholders of state-run Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Wednesday approved the distribution of dividends worth RON2.2 million from the 2020 profit, more
-
EIB Lends EUR250M to Romania for Iasi Regional Hospital
04.20.2021
The European Investment Bank (EIB) will grant a EUR250 million 27-year financing to Romania for a regional 850-bed hospital in Iasi, northeastern Romania. more
-
SIF Oltenia Reaches 23% Ownership In Antibiotice Iasi
04.14.2021
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, said in a stock market report on Wednesday that regional investment fund SIF Oltenia (SIF5.RO) reached more
-
Fashion Retailer Marc O’Polo Opens Its First Store In Northeast Romania, Within Palas Iasi Shopping Center
04.12.2021
Scandinavian fashion retailer Marc O’Polo has opened its first store in northeast Romania, within the Palas Iasi shopping center; the retailer already is present within Iulius Mall Cluj. more
-
Antibiotice Iasi Investments Double YoY To RON14M In 2020
03.24.2021
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has invested RON14 million in new product research and equipment in 2020, double compared with 2019, per more
-
Antibiotice Iasi Seeks to Distribute RON2.2M as Dividends
03.18.2021
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, plans to distribute RON2.2 million as dividends from its 2020 profit of RON26 million profit. more
-
Oresa Buys Solo Iasi Industrial Park in Northeast Romania
03.16.2021
Investment fund Oresa has completed the acquisition of the Solo Iasi industrial and logistics park from tester group, owned by Bogdan Pitigoi, marking the fund's entry on the local real estate market. more
-
Amazon Consolidates Presence In Palas Campus Iasi, A EUR120M Project Of Iulius Group
03.11.2021
Giant Amazon will have a majority presence in Palas Campus, a project worth EUR120 million of Iulius Group, which is to become one of Amazon’s most powerful centers in Europe. more
-
Antibiotice Iasi Net Profit Drops 16% in 2002, to RON25M
02.25.2021
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Thursday reported a 16% drop in net profit in 2002, to RON25 million. more
-
Vel Pitar Invests Over RON50M in Upgrading Plant in Iasi
09.04.2020
Vel Pitar, the leader of the local milling and bakery market, is investing more than 50 million lei in upgrading its plant in Iasi and expanding the product range, the company officials say. more
-
Antibiotice Iasi Enters US and UK Markets with Covid-19 Medication
07.09.2020
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has entered the US and UK markets with new medicines for Covid-19 by attending and winning tenders in the US and UK. more
-
Antibiotice Iasi Extends CEO's Mandate For Four Years
05.20.2020
-
Antibiotice Iasi Approves RON20M Dividends: 5.6% Yield
04.09.2020
-
Realty Developer Iulius Invests Over EUR160M In Expanding Palas Project In Iasi
03.02.2020
-
Antibiotice Iasi Net Profit Declines 10% in 2019, to RON30.8M
02.27.2020
State-owned Antibiotice Iasi (ATB.RO), one of the leading local pharmaceutical manufacturers, said Thursday its net profit declined 10% in 2019, to RON30.8 million, while sales revenue grew 6.8%, to more
-
Office Space Stock In Iasi To Double Over Next Five Years
02.26.2020
The office space stock in Iasi, 280,000 square meters at the moment, will double in the next five years. more
-
Antibiotice Iasi Posts RON242M Sales, RON21.5M Net Profit In Jan-Sept 2019
11.15.2019
Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Friday said it ended the first nine months of 2019 with sales revenue of RON242 million, comparable with the result reported more
-
Antibiotice Iasi Plans To Register Over 25 Products In Vietnam
10.08.2019
Antibiotice Iasi, one of the leading players in the local pharmaceuticals industry and the main producer of the active substance nystatin globally, plans to register in Vietnam over 25 products in more
-
Antibiotice Iasi To Start Payment Of RON6.7M Dividends As Of Sept 20
09.06.2019
-
Antibiotice Iasi Posts Higher Sales, Profit in 1H/2019
08.08.2019
Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Thursday reported total sales of RON172.3 million in the first half of the year, up 9%, and a net profit of RON22.3 million, more
-
Continental Expands Iasi Offices in EUR27M Investment
06.14.2019
German-held Continental has started works to expand its office building in Iasi, northeastern Romania, in a EUR27 million investment. more